drugset / Trial / NCT04644016

Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders

NCT04644016

Phase 2 Recruiting 31 enrolled Memorial Sloan Kettering Cancer Center
Non-randomizedParallel-groupOpen-labelTreatment

Summary

This is a single-arm study to investigate 1-year treatment related mortality (TRM) in patients with life threatening non-malignant and malignant hematologic disorders who do not have a matched related donor for allogeneic transplantation.

Timeline

Start
2020-11-20
Primary completion
2026-12-20
Completion
2026-12-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Cord Blood Graft Unknown
Background Busulfan Small molecule Intravenous
Background Clofarabine Other / unclassified Intravenous
Background Cyclosporine Peptide
Background Fludarabine Small molecule Intravenous
Background Mycophenolate Mofetil Small molecule Intravenous